Gene expression analysis of chromosomal regions with gain or loss of genetic material detected by comparative genomic hybridization

Comparative genomic hybridization (CGH) has been widely used to detect copy number alterations in cancer and to identify regions containing candidate tumor‐responsible genes; however, gene expression changes have been described only in highly amplified regions (amplicons). To study the overall impact of slight copy number changes on gene expression, we analyzed 16 T‐cell lymphomas by using CGH and a custom‐designed cDNA microarray containing 7,657 genes and expressed sequence tags related to tumorigenesis. We evaluated mean gene expression and variability within CGH‐altered regions and explored the relationship between the effects of the gene and its position within these regions. Minimally overlapping CGH candidate areas (6q25, 13q21–q22, and 19q13.1) revealed a weak relationship between altered genomic content and gene expression. However, some candidate genes showed modified expression within these regions in the majority of tumors; these candidate genes were evaluated and confirmed in another independent series of 23 T‐cell lymphomas by use of the same cDNA microarray and by FISH on a tissue microarray. When all the CGH regions detected for each tumor were considered, we found a significant increase or decrease in the mean expression of the genes contained in gained or lost regions, respectively. In addition, we found that the expression of a gene was dependent not only on its position within an altered region but also on its own mechanism of regulation: genes in the same altered region responded very differently to the gain or loss of genetic material. Supplementary material for this article can be found on the Genes, Chromosomes, and Cancer website at http://www.interscience.wiley.com/jpages/1045‐2257/suppmat/index.html. © 2004 Wiley‐Liss, Inc.

[1]  J. Benítez,et al.  Expression Profiling of T-Cell Lymphomas Differentiates Peripheral and Lymphoblastic Lymphomas and Defines Survival Related Genes , 2004, Clinical Cancer Research.

[2]  J. Muche,et al.  Genomic aberrations and survival in cutaneous T cell lymphomas. , 2004, The Journal of investigative dermatology.

[3]  J. Veltman,et al.  12p-Amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH , 2003, Oncogene.

[4]  J. Cigudosa,et al.  Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  S. Whittaker,et al.  Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma , 2003, Genes, chromosomes & cancer.

[6]  Joaquín Dopazo,et al.  Gene expression data preprocessing , 2003, Bioinform..

[7]  Jonathan R. Pollack,et al.  Characterizing the physical genome , 2002, Nature Genetics.

[8]  A. Dopazo,et al.  Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. , 2002, The American journal of pathology.

[9]  H. Müller-Hermelink,et al.  Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma. , 2002, The American journal of pathology.

[10]  M. Ringnér,et al.  Impact of DNA amplification on gene expression patterns in breast cancer. , 2002, Cancer research.

[11]  Christian A. Rees,et al.  Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Cornillet‐Lefèbvre,et al.  Compilation of published comparative genomic hybridization studies. , 2002, Cancer genetics and cytogenetics.

[13]  Keith Wilson,et al.  Silence of chromosomal amplifications in colon cancer. , 2002, Cancer research.

[14]  A. Dopazo,et al.  Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. , 2002, The American journal of pathology.

[15]  O. Monni,et al.  New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. , 2001, Cancer research.

[16]  W. Linehan,et al.  The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. , 2001, Cancer research.

[17]  M. Urioste,et al.  Chromosomal changes pattern and gene amplification in T cell non-Hodgkin's lymphomas , 2001, Leukemia.

[18]  V. Carey,et al.  Mixed-Effects Models in S and S-Plus , 2001 .

[19]  A. Jauch,et al.  Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course. , 2001, Blood.

[20]  J. Benítez,et al.  IgH, TCR-gamma, and TCR-beta gene rearrangement in 80 B- and T-cell non-Hodgkin's lymphomas: study of the association between proliferation and the so-called "aberrant" patterns. , 2001, Diagnostic molecular pathology (Print).

[21]  Michael L. Bittner,et al.  Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Y. Ko,et al.  Comparative genomic hybridization study of nasal-type NK/T-cell lymphoma. , 2001, Cytometry.

[23]  M. Soloski.  Recognition of tumor cells by the innate immune system. , 2001, Current opinion in immunology.

[24]  M. Caligiuri,et al.  Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Knuutila,et al.  Online access to CGH data of DNA sequence copy number changes. , 2000, The American journal of pathology.

[26]  Hongyue Dai,et al.  Widespread aneuploidy revealed by DNA microarray expression profiling , 2000, Nature Genetics.

[27]  B. Rayet,et al.  Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.

[28]  Y. Kwong,et al.  Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations. , 1999, The American journal of pathology.

[29]  K Autio,et al.  DNA copy number losses in human neoplasms. , 1999, The American journal of pathology.

[30]  R. Hay,et al.  Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα , 1999, Oncogene.

[31]  B. Kahn-Perlès,et al.  Physical interaction of the bHLH LYL1 protein and NF-κB1 p105 , 1999, Oncogene.

[32]  R. Hay,et al.  Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. , 1999, Oncogene.

[33]  B. Kahn-Perlès,et al.  Physical interaction of the bHLH LYL1 protein and NF-kappaB1 p105. , 1999, Oncogene.

[34]  S. Knuutila,et al.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. , 1998, The American journal of pathology.

[35]  K. Franssila,et al.  BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. , 1997, Blood.

[36]  K. Franssila,et al.  BCL 2 Overexpression Associated With Chromosomal Amplification in Diffuse Large B-Cell Lymphoma , 1997 .

[37]  J. Eberwine,et al.  Amplification of mRNA populations using aRNA generated from immobilized oligo(dT)-T7 primed cDNA. , 1996, BioTechniques.

[38]  B. Schlegelberger,et al.  Classification of peripheral T-cell lymphomas: cytogenetic findings support the updated Kiel classification. , 1996, Leukemia & lymphoma.

[39]  J Piper,et al.  Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors , 1994, Genes, chromosomes & cancer.